technical analysis

Bears have not yet gained the right to be given the benefit of the doubt.
I expect the volatility to continue after earnings.
The 50-day moving average is a good guide to find support and resistance.
Because every stock has a unique personality that requires its own strategy.
The chart indicates significantly less demand for the products of companies like Toll Brothers.
Volume is supporting this rally but momentum has faded.
Valeant Pharmaceuticals hasn't convinced buyers to return, that's what my charts say.
The bear is in control.
There are no bullish divergences of consequence to suggest that the stock might be poised to rally.
The stock may be sticky on the downside but that is not enough of a reason to become bullish.

Columnist Conversations

The integrity of the channel parameters on the General Electric GE chart could be a tell as to the short-to-in...
In mid August we added some Dec QCOM calls on a rollup, we take these off now. SOLD QCOM DEC 62.5 CALL AT 6...
Seeing a similar early start to trading as of yesterday.  Open pretty flat follow by reversal, especially...
Not pretty, but former net/net (and current double-net) up 15% yesterday on 2 1/2 times normal average volume ...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.